Extensively Drug-Resistant Tuberculosis (XDR-TB) presents a critical global health challenge, caused by Mycobacterium tuberculosis strains that are resistant to first-line drugs, fluoroquinolones, and at least one additional second-line injectable drug or novel agent like bedaquiline. https://livepositively.com/unlocking-value-pricing-regulatory-landscape-and-future-forecast-for-the-ocular-bromfenac-market-2025-2032/